Movement is changed in pain, but the mechanisms remain unclear. Key questions are unresolved such as whether activation can be inhomogeneously distributed within a muscle in a manner that is specific to the location of noxious input. This study addressed this question using high-density electromyography (EMG) to study regional redistribution of muscle activation within the vasti muscles and changes in knee extension force direction in response to noxious stimulation applied to muscular and nonmuscular tissues around the knee. Fourteen participants performed a low-force knee extension contraction at baseline, during, and after pain induced in 4 locations (infrapatellar fat pad, vastus lateralis, distal vastus medialis, or proximal vastus medialis). The knee extension force direction was estimated from a 3-dimensional load cell positioned just above the ankle. Regional muscle activation was estimated from amplitude of high-density surface EMG signals from vastus medialis and lateralis. Pain-induced spatial variations of activation were identified as the position of the 5 channels that showed the largest decrease (or smallest increase) in amplitude from baseline to pain or after pain. Knee extension force was produced more medially during pain after infrapatellar pad injection only (P 5 0.01). Preferential reduction of activation of the distal region of vastus medialis was observed when distal vastus medialis (P , 0.001) or vastus lateralis (P , 0.05) was injected. Both adaptations persisted after pain resolution. These results support the hypothesis that specific adaptation depends on the location of a noxious stimulus and imply that recovery of pain is not necessarily concomitant with return of the EMG to prepain patterns.
Introduction
Pain-adaptation theories propose that motor strategies change purposefully during pain, to reduce stress on irritated tissues. 17, 25 Adaptation of muscles that act on the knee can be investigated using transient acute pain elicited by hypertonic saline injection into the muscles 33 or infrapatellar fat pad (FP). 1 Adaptations to unload these muscular or nonmuscular tissues to reduce nociceptive activity might be expected to depend on the location of noxious stimulus. Consistent with this proposal, knee extension force angle changes during noxious stimulation of the medial fat pad, presumably to unload the painful tissue. 35 Likewise, noxious stimulation of specific muscle regions would be expected to change muscle activation to protect the irritated muscle tissue. Yet, when vasti muscle activation (electromyography [EMG] ) or muscle stress (shear wave elastography) has been investigated in the region of noxious input, consistent decreases have only been observed when the contralateral limb could produce compensatory force in a bilateral task, 19, 33 but not during unilateral, isometric knee extension when redistribution of activity between muscles/muscle regions, within a limb, would be required to unload the painful part. 19, 33 Failure to observe such changes might be explained by the limitations of single-channel EMG, which assess net changes in a broad muscle area, precluding observation of changes in individual units/small areas.
The complex anatomy of the quadriceps muscle 2 and its potential to produce forces in different directions 23 makes interpretation of changes in muscle activation difficult when measured from a single region. Furthermore, as motoneurones innervate muscle fibers that are spatially localized to regions within the vastus medialis (VM) 12, 13 and rectus femoris (RF), 4 variation of motor unit recruitment between regions within each quadriceps muscle may be a strategy to adapt to pain. Potential for regional variation of vasti muscle activity with intramuscular saline injection has been observed when measured with intramuscular electrodes in 8 locations within VM and vastus lateralis (VL). 36 However, the spatial interpretation of this finding is unclear because the location of the intramuscular electrode within the motor unit territory is unknown. High-density surface electromyography (HDsEMG) has revealed regional redistribution of activation within other large, multifunctional muscles such as the trapezius 8, 24 and masseter. 5 This technique provides a powerful tool to assess regional variation of muscle activation in response to experimental pain. As some data also show persistence of modified motor unit recruitment strategy after pain resolution, 34 HDsEMG could identify whether this maintains redistribution of activation between regions of the muscle.
This study aimed to determine whether (1) quadriceps muscle activation and (2) knee force direction are modulated in a manner that is specific to location of acute noxious input (experimental pain) at different locations within the quadriceps muscle and nonmuscular tissue of the knee. We hypothesized that activation would be inhomogeneously reduced across regions of the quadriceps muscle, and that adaptation of muscle activation and force direction would differ when experimental pain is induced in different locations. We also investigated whether adaptive motor strategies persist after pain resolution.
Methods

Participants
Fourteen individuals with no current knee pain and no history of lower-limb surgery or neuromuscular disorders participated in this study (7 women; 18-47 years old). Participants provided written informed consent before the experimental session. The study conformed to the standards of the latest revision of the Declaration of Helsinki (2013) and was approved by the Human Research Ethics committee of the University of Queensland (2004000654).
Experimental protocol
The dominant leg (leg used to kick a ball) was tested for all participants. Sitting in a custom-built chair, participants performed isometric knee extension contractions with the hip flexed to 100˚and the knee flexed to 60˚from full extension. Participants were asked to keep their arms crossed over their chest during all contractions and were visually monitored to avoid visible compensations or changes in posture. The ankle was strapped to a 3D force sensor (Sensix, Poitiers, France), positioned 2 cm proximal to the medial malleolus. At the beginning of the session, participants performed 3 maximal isometric voluntary contractions (MVCs) of the knee extensor muscles for 5 seconds with strong verbal encouragement.
Electromyography and force recordings
The skin was cleaned with abrasive gel (Neuprep, Weaver and Co, Aurora, CO), and surface EMG signals from VM and VL were collected using 2 HDsEMG grids of 64 electrodes (semidisposable adhesive matrix; OTBioelettronica, Torino, Italy) arranged in 5 columns and 13 rows spaced by 8 mm (Fig. 1) . Each grid was placed with its long axis aligned to the muscle innervation zone. The innervation zone was localized before electrode placement using a linear electrode array placed along the approximate muscle fibre direction (16 silver bar electrodes, 10-mm interelectrode distance, OTBioelettronica) that was moved over different regions of the muscle while the participants maintained a low-force isometric knee extension contraction. The medial and lateral boundaries of VM and VL were identified before grid placement using ultrasound imaging (Logiq e, GE Medical Systems, Chicago, IL) to ensure that all the electrodes were placed over the muscle of interest. The electrode grid was held in place using biadhesive foam. Conductive paste (Ten20, Weaver and Co) facilitated good electrical contact between the skin and electrodes. Reference electrodes were placed over the patella and the medial and lateral femoral condyles. High-density surface electromyography signals were collected in monopolar mode using an HDsEMG amplifier (128-channel EMG-USB; OTBioelettronica, Torino, Italy). Highdensity surface electromyography signals were amplified 3500 and digitized at 2048 Hz using a 12-bit A/D converter.
As a surrogate measure for forces applied to the patella and the potential pressure on the infrapatellar fat pad, 3-dimensional components of the isometric knee extension force were recorded using a triaxial force sensor (Sensix, Poitier, France), amplified (3500), filtered (low-pass 750 Hz), and collected using the HDsEMG amplifier. Surface EMG of the RF muscle was collected using a pair of electrodes (Ambu Blue Sensor N, Bellerup, Denmark-interelectrode distance: 20 mm), placed over the RF muscle belly, ;5 cm proximal to the VM grid. Rectus femoris EMG signals were preamplified (31000, Wave Wireless EMG, Cometa, Italy), filtered 10 to 500 Hz, digitized at 2000 Hz using a 1401 (CED, Cambridge, United Kingdom), and collected using Spike2 v7 (CED). To synchronize the force and EMG recordings, the force signal was split and simultaneously digitized by the 2 acquisition systems. 
Experimental knee pain
Acute pain was induced by single-bolus injections of hypertonic saline (medial infrapatellar fat pad: 0.25 mL, 5%; muscle: 0.5 mL, 7%), using a 1-mL syringe and 25-G needle (25 mm). The order of the injections was randomized before each experiment. Injection into the medial infrapatellar fat pad was performed according to previous studies. 16 Muscle injections were performed ;5 mm medially to row 12 (distal vastus medialis [VMD]), laterally to row 2 (proximal vastus medialis [VMP]), or medially to row 4 (VL, Fig. 1 ). Pain intensity was assessed using a numeric rating scale from 0 to 10, anchored with "no pain" at 0 and "worst pain imaginable" at 10. Participants rated the level of pain they experienced during each contraction immediately after the contraction was completed. Participants also marked the outline of the painful area on their leg at the end of each condition; photographs were taken and scanned to trace the painful regions. As muscle twitches and cramping were reported after saline injection during pilot testing, participants were asked to report the occurrence of any involuntary muscle activation after the injections. Eight of 14 participants were naive to hypertonic saline injections. Similarly to previous studies 3, 20, 29 and because of the large number of injections required, we did not have a control condition where isotonic saline is injected. As isotonic saline injections have not been shown to change vasti neuromuscular activation 27, 30 or regional muscle activation 8, 24 in multiple previous experiments, we did not consider it essential to include a nonpainful injection control condition in this study.
Voluntary contractions
The experimental task consisted of 5 repetitions of a 10% MVC isometric knee extension ramp contraction with visual feedback (5-second ramping up, 10-second hold, 5-second ramping down, and 10-second rest). Each set of 5 ramps was performed before the first injection (baseline), after each of 4 injections of hypertonic saline solution in different locations, respectively, beginning when the participant reported a pain of at least 3/10 (pain), and ;1 minute after resolution of the pain (0/10; post-pain) for each of the pain locations, respectively. Before the baseline trial, participants performed the 5 ramps once to familiarize themselves with the task.
Data analysis
Signals were imported and analyzed using Matlab (v.2016a; The MathWorks, Natick, MA). Pain ratings were averaged across the 5 ramps for each pain condition. Force signals were low-pass filtered at 10 Hz (Butterworth, 2nd order). In line with a previous study, 27 changes in the direction of force were quantified as the angle between the knee extension and tangential force vectors (FX: mediolateral; FY: proximodistal). The average knee extension force amplitude and force direction angles were averaged across the 5 ramps. For each trial, the force offset (calculated 500 ms before the beginning of the first ramp) was subtracted from the average value to account for subtle changes in lower-limb position between trials.
Electromyography signals were band-pass filtered at 10 to 400 Hz (Butterworth, 2nd order). Quality of the surface EMG signals was carefully assessed and HDsEMG channels that showed noise or large 50-Hz interference (due to poor skinelectrode contact) were excluded and replaced by the linear interpolation of 4 adjacent channels. For each ramp, a 5-second epoch between the 4th and 9th second of the 10-second hold phase was extracted and used for the analyses of both EMG and force. The intensity of muscle activation was calculated as the average rectified value (ARV) from each channel of the grid (VM and VL) and the electrode pair (RF) within the same 5-second epoch of each ramp. This resulted in 2 ARV amplitude spatial distributions (13 3 5 channels, VM and VL) and a single ARV value for RF for each condition. The overall activation level of VM and VL was quantified as the average of the 5 highest amplitude values across the electrode grid. To characterize spatial variations of the EMG distribution in the pain and post-pain conditions, distributions of normalized change scores (NCS) were calculated using the following formula for each channel of the grid:
where i is the channel of the grid, TRIAL is the ARV distribution of VM or VL during individual pain and post-pain conditions, BAS is the ARV distribution of VM or VL at baseline (before any injections), and BAS MEAN is the average across all the channels of the grid during baseline trials. To ensure that the results of the study were not influenced by the normalization procedure, the analyses were repeated normalizing the change score of each channel to the baseline value of the same channel, as opposed to the average of all channels at baseline. The statistical results were similar between the 2 analyses (data not reported).
Hence, NCS describe the percentage change of EMG amplitude for each channel of the grid relative to baseline. To identify any regional reduction in muscle activation across conditions, the 5 channels with the lowest NCS were identified (ie, towards negative values); this procedure identified channels with the largest decrease (or the smallest increase) of EMG amplitude during the pain or post-pain conditions compared with baseline. The identified channels were characterized in terms of position (barycenter of their coordinates) and intensity (average value). The proximodistal coordinate of the barycenter, which is related to the position of the active muscle fibers within the VM, 11 was used to represent regional activation within the VM and VL.
Statistical analysis
Statistical analyses were performed using SPSS version 22 (IBM Inc, Armonk, NY). Parametric or nonparametric tests were used according to the normality of the distribution of the data as determined with the Shapiro-Wilk test. When Mauchly test identified a violation of the assumption of sphericity, a Greenhouse-Geisser correction was applied. All factors were considered within subject. Pain scores were averaged across the 5 ramps and compared across the 4 injection locations (FP, VMD, VMP, and VL) using the Friedman test. Separate tests were performed for force and EMG amplitude analyses to compare baseline with pain, and baseline with post-pain. One-way analysis of variances (ANOVAs) were used to identify differences between baseline and pain (all 4 locations) and between baseline and postpain (4 locations) for normalized knee extension force and force direction angles; when significant, planned contrasts were used as post hoc analyses to identify which locations significantly differed from baseline. Similarly, Friedman tests were used to test whether VM, VL, and RF EMG amplitude differed between baseline and the 4 injection locations, separately for pain and post-pain; post hoc analyses involved paired Wilcoxon tests to compare each individual location with baseline.
For VM and VL, additional analyses were undertaken to quantify EMG amplitude changes accounting for regional redistribution within the muscle. To identify whether muscle activity was consistently reduced in a specific region during pain, 2-way ANOVAs were used to test the effect of location and pain condition (pain/post-pain) on the position of the channels with lowest NCS; post hoc tests identified which conditions were significantly different from 7 (ie, the midpoint of the electrode grid); if the channels showing the largest decrease were scattered across the grid, or inconsistent across participants, their average position would be close to the middle of the grid; instead, if they were consistently clustered in the proximal or distal region, a significant difference from baseline would be observed. Bonferroni correction for multiple comparisons was applied to all post hoc tests by multiplying the P value by the number of tests. Statistical significance was set at P # 0.05.
Results
Participants generally reported pain in the proximity of the injection site (Fig. 1) . Pain intensity did not differ across locations (P 5 0.2; FP: 2.9 6 1.1; VMD: 3.4 6 1.2; VMP: 3.3 6 1.1; VL: 3.1 6 1.3). Injections were performed 21.0 6 5.2 minutes apart; the tasks for the post-pain condition started ;1 minute after pain returned to 0/ 10, which was 13.8 6 4.8 minutes after the participant reported a pain level of at least 3/10. Nine (7 men) of the 14 participants reported cramping or repetitive muscle twitches after the hypertonic saline injection. These were confirmed by the EMG data (Fig. 2) . Involuntary muscle activation was observed after injection in VMP (5 participants), VMD (3 participants), VL (2 participants), but never after FP injection. One participant reported twitching and cramps in more than one location. Cramping and twitches started either before, during, or after the submaximal force task. Visual observation of the EMG distribution revealed that muscle fiber twitching/cramping was spatially localized in proximity of the site of injection (Fig. 2) . Because of cramping and twitches observed during the submaximal contractions, 7 ramps from 4 participants were excluded from the subsequent analysis. Neither the normalized knee extension force, nor the proximaldistal force production angle differed from baseline during pain (extension: F(4,52) 5 1.01, P 5 0.41, average across all conditions, pain: 10.0 6 0.3% MVC; proximal-distal: F(4,52) 5 1.96, pain: P 5 0.11, 10.3 6 7.0˚) or post-pain (extension: F(4,52), P 5 0.14, 10.0 6 0.3% MVC; proximal-distal: F(4,52) 5 1.53, P 5 0.21, 10.1 6 6.3˚) conditions. In the mediolateral direction, participants produced forces angled 14.4 6 4.4˚laterally from the knee extension force vector at baseline. Force was produced more medially both during pain (F(4,52) 5 3.46, P 5 0.01) and post-pain (F(4,52) 5 6.34, P , 0.01; Fig.3 ). Post hoc analysis indicated the mediolateral force direction was 3.5 6 3.2˚more medial during pain for FP (P 5 0.01) but did not change significantly for any of the muscle injections (P . 0.73). After pain had resolved, force was produced more medially than at baseline for FP (P 5 0.01), VMD, and VMP (P , 0.05) but not after VL injection (P 5 0.24).
During pain, Friedman tests revealed that surface EMG amplitude significantly decreased for VM (average of 5 recording sites with highest EMG; P , 0.05) and increased for RF (single electrode pair; P 5 0.05), but no consistent changes across participants were observed for VL (average of 5 recording sites with highest EMG; P 5 0.43). Although responses generally differed between individuals, a tendency for the activation of VM and VL to change in the same direction was observed (Fig. 4) . After Bonferroni correction, post hoc analysis with paired Wilcoxon tests identified only a tendency for decreased VM EMG amplitude when VMD was injected (median decrease: 10.4%; Bonferroni-adjusted P 5 0.08); and no significant change for the other locations (P . 0.76). When the FP was injected, there was a tendency for RF surface EMG amplitude to increase by 12.6%; however, this was not significant (Bonferroni-adjusted P 5 0.09). Large variability was observed across participants such that no consistent changes were observed when the noxious stimulus was localized in the other muscle locations (P . 0.9). Surface EMG amplitude did not differ from baseline for any of the muscles tested after pain (P . 0.84).
The 5 channels with the lowest NCS (ie, larger decrease or smallest increase of EMG amplitude from baseline) were adjacent to each other in most trials (representative participants in Figs. 5 and 6). For VM, a 2-way ANOVA identified a main effect of injection location (F(3,39) 5 2.89, P , 0.05), but no difference between pain and post-pain (F(1,13) 5 1.39, P 5 0.26) or interaction between these factors (F(3,39) 5 0.32, P 5 0.81). As no interactions were observed, values during and after pain were averaged before post hoc comparisons. The channels with lowest NCS were significantly more distal than the midpoint of the electrode grid when VMD was injected (3.1 6 1.2 interelectrode distances, t 5 9.7, Bonferroni-adjusted P , 0.001), and a similar change in VMD was also observed when VL was injected (2.1 6 2.3 interelectrode distances, t 5 3.4, Bonferroni-adjusted P , 0.05). As an additional analysis, we also compared whether the effect of injection was influenced by the condition that preceded it. This analysis revealed no significant effect. No significant effects were observed for distribution of activation within VL (P . 0.11) or on the mediolateral coordinate of the location for either VM (P . 0.19) or VL (P . 0.09).
Discussion
The results of this study show adaptations in force and muscle activation that depend on the location of noxious stimulus. Three key observations were made. First, regional modulation of the quadriceps was observed in response to acute noxious stimulation of the distal region of the vastus medialis or VL. Second, force direction was modified after medial infrapatellar fat pad injections, but without consistent regional variation in muscle activation. Third, motor adaptations were maintained even after pain resolution.
The specificity of adaptation of force direction and muscle activation to different locations of the noxious stimulus suggests a purposeful adaptation to protect the painful region. 17 Early changes in force direction were consistently observed when the medial infrapatellar fat pad was injected, whereas changes after VM muscle injections reached statistical significance only after pain. Although consistent across participants, the relevance of the small (on average ,4˚) change in knee extension force direction observed in this study cannot be ascertained. However, it should be considered that knee extension force direction was used as a surrogate measure for forces applied to the patella-even a small change in external force direction may possibly reflect a large change in patellofemoral joint forces. It is possible that the medial infrapatellar fat pad may be unloaded by posterior translation of the medial tibial condyle, which combined with knee extension, could underlie a more medially directed force vector at the ankle. The only trend for consistent change in muscle activation after injection of the fat pad was increased rectus femoris activation. Although not possible to resolve from this study, RF has a role in external rotation of the femur, which may contribute to the change in knee extension force vector. The absence of systematic changes in vasti activation with FP injections suggests that the changes in knee extension force direction may be due to changes in activation of muscles other than the vasti.
Consistent changes of VM activation were observed in response to VMD injection, which led to changes in spatial distribution and decreased amplitude. The location of the EMG channels with lowest change scores (ie, greatest decrease or smallest increase) identifies that, regardless of whether activation of the VM muscle as a whole increased, decreased, or did not change with pain, the activation of the distal region of the muscle was relatively less than the remainder of the muscle during distal VM pain. This suggests preferential unloading/less loading of the region in which nociceptive stimulation was applied. Interestingly, similar changes in the amplitude distribution within the VM were observed when VL was injected with hypertonic saline, although to a lesser extent and less consistently across participants. This stereotypical redistribution of activation seems to be, in part, consistent with that observed when noxious stimuli were applied to different regions of the upper trapezius. 7, 8 The absence of changes in spatial distribution when VMP was injected may be related to the different function of the distal (patellar stabilization) vs proximal (knee extension) regions of the vasti, 23 although further interpretation of this proposal is beyond the scope of the present investigation. Taken together, the results provide some support for the hypothesis that adaptation depends on the location of pain because noxious stimulation of nonmuscular (medial infrapatellar fat pad) tissues mainly resulted in changes in force direction, whereas noxious stimulation of VMD or VL mainly resulted in regional changes in VM regional activation.
The results of this study show preferential modulation of individual quadriceps heads and regions within an individual head instead of uniform inhibition of the agonist muscles in the presence of pain. Across participants, changes in VM and VL activation were generally observed in the same direction (ie, both muscles either increased or decreased activation); however, VM activation reduced in response to noxious input of VM, more consistently than VL (Fig. 4) . Vastus medialis and VL share synaptic input, 22 and their activity is usually comodulated in response to pain, 19 voluntary activation, 18 and fatigue. 21 By contrast, experimental joint effusion shows that afferent input affects the quadriceps motoneurone pool inhomogeneously because spinal excitability of VM was reduced with lower volumes of effusion and to a greater extent than VL or RF. 31 Differences in relative timing and amplitude of activation of VM and VL in association with experimental pain, 16 delayed onset muscle soreness, 15 and patellofemoral pain syndrome 6 provide further evidence of partly inhomogeneous effects of pain on the drive to vasti muscles. In addition, although several previous experiments found no evidence for a systematic decrease in VM EMG amplitude during isometric contractions when noxious input was applied to VM, 18, 19 here, we demonstrated a trend (although nonsignificant) for decreased activation in 11/14 participants. A possible reason for these differences when compared with previous studies is that changes were observed only in the distal VM when the hypertonic saline solution was injected in the same muscle region. Similar to Hug et al., 18 we observed no consistent changes in EMG in a more proximal (less distal) muscle region when that region was injected.
In this study, some adaptations were observed during pain and persisted after pain resolution, whereas others were only observed either during pain or after pain resolution. Our findings of altered distribution of activation within the muscle, but unchanged overall activation after pain agrees with the observation that motor unit discharge rate, but not the population of recruited motor units, returns to baseline after pain resolution. 34 The nonhomogeneous time-course concurs with other studies that showed adaptation to corticospinal excitability both during and after pain resolution, 28, 32 but adaptation of spinal excitability only after pain resolution. 26 Although speculative, this may provide some indication of the underlying mechanisms. The immediate effect of muscle injection on distribution of muscle activity may depend on adaptation to the descending command from the motor cortex, whereas the late impact of muscle injection on force direction may depend on spinal mechanisms. The time-course of effect of FP injection on knee force direction similarly implies cortical involvement, yet why this would differ with the mechanism for muscle injection is unclear. Although not explaining the apparent difference in time-course of some changes, one possibility for the persistence of changes after pain resolution may be that pain is a motivator to adapt (presumably to protect the tissues), but resolution of pain is not necessarily a motivator to adapt back to the prepain state. 17 Involuntary muscle activation, in the form of localized cramp or repetitive muscle twitching, was observed after 10/42 muscle injections (9/14 participants), but never after infrapatellar fat pad injections. Visual analysis revealed that the action potentials were highly localized in close proximity to the injection location. When single differential signals were calculated from the monopolar recordings, the innervation zone and action potential propagation could be observed in all cases (Fig. 2) . This strongly suggests the involuntary muscle activation is generated from the motor end plate. The higher incidence of this phenomenon in this study than previous reports may relate to the location of the injections, which was performed in proximity of the innervation zone. Although previous research reported no changes in muscle fiber membrane properties after hypertonic saline injection (indirectly measured as action potential conduction velocity 9 ), direct peripheral effect of the saline solution on the neuromuscular junction cannot be excluded, especially when the injection is performed in proximity of the innervation zone. The highly localized involuntary activation in the HDsEMG recording supports 3 features of neuromuscular organization, which are important for interpretation of the broader findings of this study. These are (1) sensory input from the hypertonic saline injection is highly localized within the muscle, as implied by imaging studies 14 ; (2) VM (and VL) motor units have most of their muscle fibers clustered within small regions of the muscle 12, 13 ; and (3) regional activation within the vasti can be observed as changes of surface EMG amplitude distribution in the proximal-distal direction in the HDsEMG recordings. 10, 11 A possible limitation of this study is that the adaptation to injections in a single location may have been influenced by the after-effect of a previous injection. However, the order of injection location was randomized, and location-specific changes were observed for all extracted indices, which suggest that a cumulative effect, if any, had a minor effect on the results.
Adaptation to acute experimental knee pain involved a systematic reduction of activation of the distal region of the VM, changes in muscle activation across the quadriceps heads, and modification of knee force direction (more medial during pain), observed to a different extent depending on whether the noxious stimulation was applied to specific locations within the quadriceps muscle tissue or to the infrapatellar fat pad. Changes in spatial distribution of activity provide evidence of inhomogeneous distribution of drive to the motoneuron pool of VM in the presence of noxious input. Regional changes in muscle activation and changes to knee force direction persisted even after pain resolution, whereas changes in overall amplitude of muscle activation returned to baseline. These findings provide new insight on the short-term adaptation to pain.
